Balchem Statistics
Total Valuation
Balchem has a market cap or net worth of $5.33 billion. The enterprise value is $5.49 billion.
| Market Cap | 5.33B |
| Enterprise Value | 5.49B |
Important Dates
The next estimated earnings date is Friday, May 2, 2025, before market open.
| Earnings Date | May 2, 2025 |
| Ex-Dividend Date | Dec 26, 2024 |
Share Statistics
Balchem has 32.53 million shares outstanding. The number of shares has increased by 0.83% in one year.
| Current Share Class | 32.53M |
| Shares Outstanding | 32.53M |
| Shares Change (YoY) | +0.83% |
| Shares Change (QoQ) | -0.72% |
| Owned by Insiders (%) | 0.63% |
| Owned by Institutions (%) | 90.17% |
| Float | 32.32M |
Valuation Ratios
The trailing PE ratio is 41.68 and the forward PE ratio is 32.43. Balchem's PEG ratio is 3.49.
| PE Ratio | 41.68 |
| Forward PE | 32.43 |
| PS Ratio | 5.55 |
| Forward PS | 5.14 |
| PB Ratio | 4.63 |
| P/TBV Ratio | 26.01 |
| P/FCF Ratio | 36.41 |
| P/OCF Ratio | 29.28 |
| PEG Ratio | 3.49 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.68, with an EV/FCF ratio of 37.50.
| EV / Earnings | 42.71 |
| EV / Sales | 5.75 |
| EV / EBITDA | 23.68 |
| EV / EBIT | 29.82 |
| EV / FCF | 37.50 |
Financial Position
The company has a current ratio of 1.99, with a Debt / Equity ratio of 0.18.
| Current Ratio | 1.99 |
| Quick Ratio | 1.07 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | 0.88 |
| Debt / FCF | 1.42 |
| Interest Coverage | 11.13 |
Financial Efficiency
Return on equity (ROE) is 11.66% and return on invested capital (ROIC) is 8.39%.
| Return on Equity (ROE) | 11.66% |
| Return on Assets (ROA) | 7.25% |
| Return on Invested Capital (ROIC) | 8.39% |
| Return on Capital Employed (ROCE) | 12.98% |
| Revenue Per Employee | $700,723 |
| Profits Per Employee | $94,398 |
| Employee Count | 1,361 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 5.14 |
Taxes
In the past 12 months, Balchem has paid $37.98 million in taxes.
| Income Tax | 37.98M |
| Effective Tax Rate | 22.82% |
Stock Price Statistics
The stock price has increased by +6.04% in the last 52 weeks. The beta is 0.63, so Balchem's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | +6.04% |
| 50-Day Moving Average | 165.17 |
| 200-Day Moving Average | 168.28 |
| Relative Strength Index (RSI) | 44.90 |
| Average Volume (20 Days) | 193,806 |
Short Selling Information
The latest short interest is 464,607, so 1.43% of the outstanding shares have been sold short.
| Short Interest | 464,607 |
| Short Previous Month | 416,523 |
| Short % of Shares Out | 1.43% |
| Short % of Float | 1.44% |
| Short Ratio (days to cover) | 2.84 |
Income Statement
In the last 12 months, Balchem had revenue of $953.68 million and earned $128.48 million in profits. Earnings per share was $3.93.
| Revenue | 953.68M |
| Gross Profit | 336.21M |
| Operating Income | 184.03M |
| Pretax Income | 147.82M |
| Net Income | 128.48M |
| EBITDA | 231.71M |
| EBIT | 184.03M |
| Earnings Per Share (EPS) | $3.93 |
Balance Sheet
The company has $49.52 million in cash and $208.04 million in debt, giving a net cash position of -$158.53 million or -$4.87 per share.
| Cash & Cash Equivalents | 49.52M |
| Total Debt | 208.04M |
| Net Cash | -158.53M |
| Net Cash Per Share | -$4.87 |
| Equity (Book Value) | 1.15B |
| Book Value Per Share | 35.35 |
| Working Capital | 156.09M |
Cash Flow
In the last 12 months, operating cash flow was $182.00 million and capital expenditures -$35.66 million, giving a free cash flow of $146.34 million.
| Operating Cash Flow | 182.00M |
| Capital Expenditures | -35.66M |
| Free Cash Flow | 146.34M |
| FCF Per Share | $4.50 |
Margins
Gross margin is 35.25%, with operating and profit margins of 19.30% and 13.47%.
| Gross Margin | 35.25% |
| Operating Margin | 19.30% |
| Pretax Margin | 17.45% |
| Profit Margin | 13.47% |
| EBITDA Margin | 24.30% |
| EBIT Margin | 19.30% |
| FCF Margin | 15.34% |
Dividends & Yields
This stock pays an annual dividend of $0.87, which amounts to a dividend yield of 0.53%.
| Dividend Per Share | $0.87 |
| Dividend Yield | 0.53% |
| Dividend Growth (YoY) | 10.13% |
| Years of Dividend Growth | 10 |
| Payout Ratio | 22.14% |
| Buyback Yield | -0.83% |
| Shareholder Yield | -0.30% |
| Earnings Yield | 2.41% |
| FCF Yield | 2.75% |
Analyst Forecast
The average price target for Balchem is $190.00, which is 16.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $190.00 |
| Price Target Difference | 16.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 21, 2010. It was a forward split with a ratio of 1.5:1.
| Last Split Date | Jan 21, 2010 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
Balchem has an Altman Z-Score of 9.34 and a Piotroski F-Score of 7.
| Altman Z-Score | 9.34 |
| Piotroski F-Score | 7 |